Barely Significant
← all excerpts

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations.

Diabetes Metab Syndr Obes · 2023 · PMC10658811 · PMID 38028995

1
hedged sentence
closest p
boldest claim

The sentences

a decreasing trendno p-value reported
However, it is noteworthy that this complication is rare and has shown a decreasing trend over time. 145–147 Moreover, the FDA has revised the metformin label to reflect its safety use in patients with an estimated glomerular filtration rate (eGFR) of 30 mL/min/1.73 m 2 . 143 Studies on metformin have also made considerable progress in understanding the genetic basis underlying its therapeutic response.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.